Led by Ohio, Midwest healthcare startups raise $996 million in 2012

Midwest healthcare companies attracted $996 million in new investments across 182 companies in 2012 according to the BioEnterprise Midwest Healthcare Venture Investment Report. The total dollars attracted is up by twenty-three percent from 2011. Ohio ($292 million), Minnesota ($165 million), and Illinois ($146 million) led Midwestern states in attracting investment dollars; Cleveland, Minneapolis, and Chicago were the leaders among Midwest regions.

“Investment activity in Midwest healthcare deals continues its upward trend, outperforming previous years’ activity for 3 years in a row. As with the rest of the country, Midwest healthcare investing fell dramatically in 2009 after strong years in 2007 and 2008, but it appears investors are again optimistic about Midwest deals. 2013 should be an interesting year to watch,” said Aram Nerpouni, Interim President of BioEnterprise, the Cleveland biomedical accelerator.

By sector, the 2012 equity funding was allocated as follows:

  • Medical device companies: $309 million (32%)
  • Healthcare IT and service companies: $177 million (18%)
  • Biopharmaceutical companies: $487 million (50%)

The Midwest Healthcare Venture Investment Report includes all reported numbers and regionally collected data. For complete state and region results across the Midwest, see table here.

photo source: oneohionow.org

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

New distribution partnership between Ganeden Biotech and Grupo Saporiti will increase availability of GanedenBC30 in South America | Ganeden Biotech, December 17, 2014

Columbus downtown building where cancer drugs were once made might be demolished | The Columbus Dispatch, December 17, 2014

Health and Human Services awards Ohio $75 million to implement and test health care payment and service delivery models, improve care, lower costs | Ohio Hospital Association, December 16, 2014

Cleveland HeartLab is the fastest growing private health care company in the Cleveland metro area according to Inc. | Inc., December 16, 2014

CincyTech portfolio companies raising $200 million in investor capital by end of 2014 | Cincinnati.com, December 16, 2014

Data presented by independent academic collaborators demonstrate ability of novel Manocept Immunotherapy to kill activated macrophages from KS patients, Macrophage Therapeutics, Navidea Biopharmaceuticals | Business Wire, December 15, 2014

Clinical Research Management (ClinicalRM) announces clinical trial evaluating effectiveness of convalescent plasma therapy for the treatment of Ebola underway in Liberia | PR Newswire, December 15, 2014

Alkermes announces initiation of clinical study of extended durations of Aripiprazole Lauroxil for treatment of schizophrenia | Business Wire, December 15, 2014

Ohio Northern University receives $1.21 million grant to instill the entrepreneurial mindset in engineering undergraduates | PR Newswire, December 15, 2014

Nationwide Children’s and OhioHealth planning campus in Delaware County | Columbus Business First, December 15, 2014

Akron couple donates $2 million for cancer research and education at Summa Health System | Akron Beacon Journal, December 13, 2014

Battelle, The Ohio State University and the Ohio Soybean Council developing improved soybean meal for aquaculture | The Fish Site, December 12, 2014

Wright-Patterson AFB Air Force Research Laboratory to hire 325 scientists and engineers in the next year | Dayton Daily News, December 12, 2014

Navidea’s Macrophage Therapeutics to present data supporting potential for breakthrough with Manocept in immunotherapy | Navidea Biopharmaceuticals, December 12, 2014

Midmark has acquired Mumbai, India-based Janak Healthcare | Dayton Business Journal, December 11, 2014

Navidea forms Macrophage Therapeutics business unit to explore therapeutic applications of Manocept | Navidea Biopharmaceuticals, December 10, 2014

Preclinical xenograft studies show positive results for EnzymeBioSystems’ Amooranin | PR Newswire, December 10, 2014

Dr. Sheldon Retchin announced as the new CEO of The Ohio State University Wexner Medical Center | The Columbus Dispatch, December 9, 2014

Dr. Andrew Redington hired as chief of cardiology and co-director of the Heart Institute at Cincinnati Children’s Hospital Medical Center | Cincinnati Business Courier, December 9, 2014

Element Materials Technology consolidating and improving operations in Fairfield | Cincinnati.com, December 9, 2014